Cover Image
市場調查報告書

Foresee Pharmaceuticals, LLC :產品平台分析

Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293971
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Foresee Pharmaceuticals, LLC :產品平台分析 Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2015
出版日期: 2015年12月30日 內容資訊: 英文 31 Pages
簡介

Foresee Pharmaceuticals, LLC 研究開發活用了獨有的穩定化注射製劑平台技術的籌備藥。從而可開發小分子,肽及蛋白質取向的控制釋放藥物輸送系統。

本報告提供Foresee Pharmaceuticals, LLC的治療藥開發平台的現狀及各開發階段比較分析,各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Foresee Pharmaceuticals, LLC的基本資料

  • Foresee Pharmaceuticals, LLC概要
  • 主要資訊
  • 企業資料

Foresee Pharmaceuticals, LLC:R&D概要

  • 主要的治療範圍

Foresee Pharmaceuticals, LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Foresee Pharmaceuticals, LLC:開發中產品概況 ▼最後階段的開發中產品

第Ⅲ階段的產品/聯合治療模式 ▼臨床實驗階段的開發中產品 第一階段的產品/聯合治療模式 ▼初期階段的開發中產品 在前臨床階段的產品/聯合治療模式 藥物研發中的產品/聯合治療模式

Foresee Pharmaceuticals, LLC:藥物簡介

  • leuprolide acetate
  • FP-025
  • FP-002
  • FP-004
  • FP-005
  • FP-007
  • FP-008
  • FP-009

Foresee Pharmaceuticals, LLC:開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Foresee Pharmaceuticals, LLC:最近的開發平台趨勢

Foresee Pharmaceuticals, LLC:暫停中的計劃

Foresee Pharmaceuticals, LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07948CDB

Summary

Global Markets Direct's, 'Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2015', provides an overview of the Foresee Pharmaceuticals, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Foresee Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Foresee Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Foresee Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Foresee Pharmaceuticals, LLC's pipeline products

Reasons to buy

  • Evaluate Foresee Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Foresee Pharmaceuticals, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Foresee Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Foresee Pharmaceuticals, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Foresee Pharmaceuticals, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Foresee Pharmaceuticals, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Foresee Pharmaceuticals, LLC Snapshot
    • Foresee Pharmaceuticals, LLC Overview
    • Key Information
    • Key Facts
  • Foresee Pharmaceuticals, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Foresee Pharmaceuticals, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Foresee Pharmaceuticals, LLC - Pipeline Products Glance
    • Foresee Pharmaceuticals, LLC - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Foresee Pharmaceuticals, LLC - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Foresee Pharmaceuticals, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Foresee Pharmaceuticals, LLC - Drug Profiles
    • leuprolide acetate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-025
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-004
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-009
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Foresee Pharmaceuticals, LLC - Pipeline Analysis
    • Foresee Pharmaceuticals, LLC - Pipeline Products by Target
    • Foresee Pharmaceuticals, LLC - Pipeline Products by Route of Administration
    • Foresee Pharmaceuticals, LLC - Pipeline Products by Molecule Type
    • Foresee Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action
  • Foresee Pharmaceuticals, LLC - Recent Pipeline Updates
  • Foresee Pharmaceuticals, LLC - Dormant Projects
  • Foresee Pharmaceuticals, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Foresee Pharmaceuticals, LLC, Key Information
  • Foresee Pharmaceuticals, LLC, Key Facts
  • Foresee Pharmaceuticals, LLC - Pipeline by Indication, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Stage of Development, 2015
  • Foresee Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2015
  • Foresee Pharmaceuticals, LLC - Phase III, 2015
  • Foresee Pharmaceuticals, LLC - Phase I, 2015
  • Foresee Pharmaceuticals, LLC - Preclinical, 2015
  • Foresee Pharmaceuticals, LLC - Discovery, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Target, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Route of Administration, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Molecule Type, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2015
  • Foresee Pharmaceuticals, LLC - Recent Pipeline Updates, 2015
  • Foresee Pharmaceuticals, LLC - Dormant Developmental Projects,2015

List of Figures

  • Foresee Pharmaceuticals, LLC - Pipeline by Top 10 Indication, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Stage of Development, 2015
  • Foresee Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Top 10 Target, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Top 10 Route of Administration, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline by Top 10 Molecule Type, 2015
  • Foresee Pharmaceuticals, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top